Home Support ISMP Newsletters Webinars Report Medication Error to ISMP Educational Resources ISMP Online Store Consulting Services FAQ Tools and Resources About ISMP Contact Us
Print This Page SitemapISMP Facebook
Site Search by PicoSearch. Help


From the July 26, 2000 issue

Safety Briefs

  • In our July 28, 1999, issue, we mentioned that poorly written orders for the anti-diabetic medication AVANDIA (rosiglitazone) can look like COUMADIN (warfarin). Both are available as 4 mg oral tablets, which increases the likelihood of a mix-up. Here's an actual prescription order for Avandia, sent to us recently, that was initially misread as Coumadin.

    Order for Avandia
    Picture of order for AVANDIA

    Fortunately, the pharmacist in this case did recognize that the prescription could be interpreted either way, and clarified with the prescriber that Avandia was intended. Since accidental administration of either drug would pose a great danger to any patient, we thought it would be worthwhile to remind physicians, nurses and pharmacists about the potential for errors. To reduce the chance of error, prescriptions for either drug should always include the medication's purpose. Also, nurses and pharmacists must clarify the purpose of either drug prior to dispensing and administration.

  • Is this a prescription for TEGRETOL (carbamazepine) or TEQUIN (gatifloxacin)? A straw poll in our office showed that all read the order as Tegretol. But it's actually an order for the antibiotic Tequin. Similarity in the available tablet strengths makes it even easier to misinterpret the drug name.

    Order for TEQUIN
    Picture of order for Tequin

    Carbamazepine is available in 100, 200, and 400 mg (extended release) oral tablets, and Tequin is also available in 200 mg or 400 mg oral tablet strengths. Familiarity and association with the word "equine" seems to invite mispronunciation and misspelling of "Tequin" with an added "E" at the end of the name (which when scripted can look like the "L" in Tegretol). Likewise, unfamiliarity with newer drugs on the market, such as Tequin, invites misinterpretation with other look-alike drug names with which staff are more familiar. As with the Avandia-Coumadin pair above, health professionals should independently confirm the patient's diagnosis before dispensing. Use reminders on drug containers and build alerts for computer systems. Also, an effective formulary addition process, which includes analysis of "error potential" and staff education, can help prevent staff from mistaking orders for newer drugs with older, more familiar drugs.

Resources
Acute Care Main Page
Current Issue
Past Issues
Recent articles
Survey Results
Action Agendas - Free CE's
Hazard Alerts
Subscribe
Contest Winners
Newsletter Editions
Acute Care
Community/Ambulatory
Nursing
Consumer
Home | Contact UsEmployment  | Legal Notices | Privacy Policy | Help Support ISMP
  Med-ERRS |   ISMP Canada |  ISMP Spain | ISMP Brasil | International Group | Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044, Phone: (215) 947-7797,  Fax: (215) 914-1492
© 2012 Institute for Safe Medication Practices. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.

Search only trustworthy HONcode health websites: